Chao‐Liang Wu
Impact in
- Biotechnology top 0.5%
- Cancer Research and Treatments
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- RNA Interference and Gene Delivery 10
- Immunology 48
- Immunotherapy and Immune Responses 14
- Immune Response and Inflammation 10
- Galectins and Cancer Biology 9
- Co-authors
- Ai‐Li Shiau (116 shared papers)Che‐Hsin Lee (23 shared papers)Chrong‐Reen Wang (22 shared papers)Yu‐Hung Chen (7 shared papers)Gia-Shing Shieh (25 shared papers)Shih‐Yao Chen (25 shared papers)Dar Bin Shieh (1 shared paper)Yu-Sheng Yang (1 shared paper)
- Journals
- International Journal of Molecular Sciences (13 papers)Scientific Reports (8 papers)Vaccine (6 papers)Gene Therapy (6 papers)Human Gene Therapy (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chao‐Liang Wu
241 papers receiving 8.0k citations
Chao‐Liang Wu's Hit Papers
Peers
Comparison fields: 5 of 163
- Biotechnology 631
- Immunology 1.1k
- Biomaterials 690
- Cancer Research 708
- Oncology 1.1k
Countries citing papers authored by Chao‐Liang Wu
This map shows the geographic impact of Chao‐Liang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Liang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Liang Wu more than expected).
Fields of papers citing papers by Chao‐Liang Wu
This network shows the impact of papers produced by Chao‐Liang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Liang Wu. The network helps show where Chao‐Liang Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chao‐Liang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications Hit paper breakdown → | 2004 | 589 |
| 2 | 2007 | 299 | |
| 3 | The role of macrophages in osteoarthritis and cartilage repair Hit paper breakdown → | 2020 | 239 |
| 4 | 2008 | 220 | |
| 5 | 2007 | 171 | |
| 6 | 2009 | 156 | |
| 7 | 2008 | 138 | |
| 8 | 2009 | 136 | |
| 9 | 2019 | 126 | |
| 10 | 2017 | 125 | |
| 11 | 2013 | 113 | |
| 12 | 2012 | 112 | |
| 13 | 2020 | 110 | |
| 14 | 2009 | 108 | |
| 15 | 2011 | 107 | |
| 16 | 2005 | 105 | |
| 17 | 2015 | 103 | |
| 18 | 1997 | 93 | |
| 19 | 2012 | 87 | |
| 20 | 2003 | 85 |
About Chao‐Liang Wu
Chao‐Liang Wu is a scholar working on Molecular Biology, Immunology, Genetics, Oncology and Biotechnology, having authored 253 papers that have together received 8.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (27 papers), Cancer Research and Treatments (23 papers), Immunotherapy and Immune Responses (14 papers), RNA Interference and Gene Delivery (10 papers), Immune Response and Inflammation (10 papers), Galectins and Cancer Biology (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). The work is most often cited by research in Biotechnology (631 citations), Immunology (1.1k citations), Biomaterials (690 citations), Cancer Research (708 citations) and Oncology (1.1k citations). Chao‐Liang Wu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ai‐Li Shiau, Che‐Hsin Lee, Chrong‐Reen Wang, Yu‐Hung Chen, Gia-Shing Shieh, Shih‐Yao Chen, Dar Bin Shieh, Yu-Sheng Yang, I‐Ming Jou and Farshid Guilak. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Vaccine, Gene Therapy and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.